SynthesisChest2026
Impact of Sex on Prediction of Asthma Attacks by Clinical Risk Factors and Type 2 Biomarkers.
Synthesis in Chest, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
26 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMultiple clinical and inflammatory risk factors for asthma attacks have been identified, including attack history, comorbidities, blood eosinophil count (BEC), and exhaled nitric oxide (Feno). However, the impact of sex on their prognostic value is unclear. RESEARCH QUESTION: Does sex modify prognostic values of clinical characteristics, BEC, and Feno for severe asthma attacks? STUDY DESIGN AND
methodsWe conducted a patient-level meta-analysis of the control arms of 22 randomized asthma trials (Oxford Asthma Attack Risk Scale Meta-Analysis [ORACLE2], N = 6,510). Annualized severe asthma attack rates and (adjusted) rate ratios (aRRs) (95% CI) were estimated with sex-specific multivariable negative binomial models, adjusting for baseline demographics, clinical characteristics, and type 2 biomarkers (BEC and Feno). Interaction tests evaluated the influence of sex on other prognostic factors.
resultsAmong 4,140 female and 2,370 male patients, crude attack rates were higher in female patients than in male patients (0.90 vs 0.74 attacks/patient-year). Prior asthma attacks were the strongest predictor of future attacks in both sexes but with a higher aRR in male individuals (aRR [95%CI], 2.76 [1.97-3.88]) than in female individuals (1.66 [1.33-2.06]; interaction P = .03). In contrast, the prognostic utility of treatment intensity, BMI, lung function, smoking status, comorbidities, and type 2 biomarkers was similar in male and female individuals. The highest risk was seen in the combined high-BEC/high- Feno groups for both sexes.
interpretationTo our knowledge, this study is the first patient-level meta-analysis of prospectively collected clinical trial data to evaluate sex as a modifier of prognostic factors for asthma attacks. The overall annualized asthma attack rate was higher in female than male individuals. Prior attack history had stronger prognostic value for future attacks in male individuals, whereas other clinical risk factors and type 2 biomarkers (blood eosinophils and Feno) showed no major sex differences. These findings highlight that female individuals without prior attacks may face increased risk, and they have important implications for clinical research and practice.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.